Price Beat Guarantee: If you find a lower price on an identical product advertised by any of our competitors, let us know and receive a 10% discount.
The competitor's price is the advertised medication price plus any shipping, handling or other fees that would be incurred when ordering from the competitor. Remember, we offer free shipping on all orders!
|
Lialda (Mesalamine Delayed Release Tablets)
Manufactured by: Shire  This product requires a valid prescription
| 
|
|
Lialda/Mezavant (Mesalamine) for the induction of remission in patients with active, mild to moderate ulcerative colitis, is the only FDA-approved, oral once-daily prescription drug. The safety and effectiveness of Lialda/Mezavant (Mesalamine) have been established in two 8-week trials.
Lialda/Mezavant contains mesalamine, the active ingredient in other ulcerative colitis medications, and has MMX technology.
All other oral mesalamine medications need to be taken 2 to 4 times per day. Lialda/Mezavant (Mesalamine) is taken just once a day.
Mesalazines are a part of a drug class called aminosalicylates which contain 5-aminosalicyclic acid (5-ASA). There are approximately a million patients worldwide with UC and more than 70% of them are being treated with mesalazinebased products
|
Cart
Live Help
Mail
